4.5 Article

Associations between Tissue Visfatin/Nicotinamide, Phosphoribosyltransferase (Nampt), Retinol Binding Protein-4, and Vaspin Concentrations and Insulin Resistance in Morbidly Obese Subjects

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Relationship between vaspin gene expression and abdominal fat distribution of Korean women

Jin A. Lee et al.

ENDOCRINE JOURNAL (2011)

Article Cardiac & Cardiovascular Systems

Association of obesity and biomarkers of inflammation and endothelial dysfunction in adults in Inner Mongolia, China

Angela M. Thompson et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)

Article Endocrinology & Metabolism

Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus

Hala O. El-Mesallamy et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2011)

Article Endocrinology & Metabolism

Vaspin (SERPINA12) Genotypes and Risk of Type 2 Diabetes: Results from the MONICA/KORA studies

K. Kempf et al.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2010)

Review Cell Biology

The Role of Adipose Tissue and Adipokines in Obesity-Related Inflammatory Diseases

Carmela Rita Balistreri et al.

MEDIATORS OF INFLAMMATION (2010)

Review Cell Biology

Inflammation, a Link between Obesity and Cardiovascular Disease

Zhaoxia Wang et al.

MEDIATORS OF INFLAMMATION (2010)

Editorial Material Endocrinology & Metabolism

Endoplasmic Reticulum Stress: Another Link Between Obesity and Insulin Resistance/Inflammation?

Guenther Boden

DIABETES (2009)

Article Medicine, General & Internal

Serum vaspin level in relation to postprandial plasma glucose concentration in subjects with diabetes

Ye Yin et al.

CHINESE MEDICAL JOURNAL (2009)

Article Agriculture, Dairy & Animal Science

Visfatin expression is not associated with adipose tissue abundance in the porcine model

Marie-France Palin et al.

DOMESTIC ANIMAL ENDOCRINOLOGY (2008)

Review Pharmacology & Pharmacy

Vaspin: a novel serpin with insulin-sensitizing effects

Jun Wada

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)

Review Pathology

Retinol-binding protein-4 in experimental and clinical metabolic disease

Maximilian von Eynatten et al.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2008)

Review Medicine, Research & Experimental

A novel adipocytokine, visceral adipose tissue-derived serine protease inhibitor (vaspin), and obesity

Q. Li et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2008)

Article Cardiac & Cardiovascular Systems

Adipokines, insulin resistance, and coronary artery calcification

Atif Qasim et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)

Article Endocrinology & Metabolism

Serum vaspin concentrations in human obesity and type 2 diabetes

Byung-Soo You et al.

DIABETES (2008)

Article Endocrinology & Metabolism

Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance

Teoman Dogru et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2007)

Article Endocrinology & Metabolism

Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians

Sreedharan Sandeep et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2007)

Article Endocrinology & Metabolism

Circulating visfatin is associated with parameters of iron metabolism in subjects with altered glucose tolerance

Jose Manuel Fernandez-Real et al.

DIABETES CARE (2007)

Review Immunology

Adipocytokines: mediators linking adipose tissue, inflammation and immunity

Herbert Tilg et al.

NATURE REVIEWS IMMUNOLOGY (2006)

Article Medicine, General & Internal

Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects

Timothy E. Graham et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Biochemistry & Molecular Biology

Vaspin gene expression in human adipose tissue:: Association with obesity and type 2 diabetes

N Klöting et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)